help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Randeva, H. S.
Right arrow Articles by Prelevic, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Randeva, H. S.
Right arrow Articles by Prelevic, G. M.
The Journal of Clinical Endocrinology & Metabolism Vol. 87, No. 10 4496-4501
Copyright © 2002 by The Endocrine Society


Original Article

Exercise Decreases Plasma Total Homocysteine in Overweight Young Women with Polycystic Ovary Syndrome

Harpal S. Randeva, Krzysztof C. Lewandowski, Józef Drzewoski, Katherine Brooke-Wavell, Chris O’Callaghan, Leszek Czupryniak, Edward W. Hillhouse and Gordana M. Prelevic

The Sir Quinton Hazel Molecular Medicine Research Centre (H.S.R., K.C.L., C.O., E.W.H.), University of Warwick, Coventry CV4 7AL, United Kingdom; Department of Diabetes and Metabolic Disorders (J.D., L.C.), The Medical University of Lodz, PL 90-131 Lodz, Poland; Department of Human Sciences (K.B.-W.), Loughborough University, Leicestershire LE11 3TU, United Kingdom; Department of Community Health and Epidemiology (C.O.), Queen’s University, Kingston, Ontario, Canada K7L 3N6; and Department of Medicine, Royal Free & University College Medical School (G.M.P.), London NW3 2PF, United Kingdom

Address all correspondence and requests for reprints to: Dr. Harpal S. Randeva, The Sir Quinton Hazel Molecular Medicine Research Centre, University of Warwick, Gibbet Hill Road, Coventry, CV4 7AL, United Kingdom. E-mail: hrandeva{at}bio.warwick.ac.uk.

Abstract

Women with polycystic ovary syndrome (PCOS) have a clustering of cardiovascular risk factors, such as obesity, lipid abnormalities, impaired glucose tolerance, insulin resistance, and hypertension. Exercise is reported to lower the incidence of cardiac events. The effect of exercise on plasma homocysteine concentrations, an independent cardiovascular risk factor, has not been previously reported in women with PCOS.

We examined the effects of exercise on plasma total homocysteine concentrations in young overweight or obese PCOS women [age (mean ± SD), 30.6 ± 6.6 yr; body mass index, 35.49 ± 7.57 kg/m2]. Twenty-one women consented to a 6-month exercise program; 12 women (exercisers) adhered to the program, whereas 9 (nonexercisers) did not. In both groups of women, the following parameters were recorded at baseline and 6 months: body mass index, waist-to-hip ratio, and aerobic capacity (maximal oxygen consumption); blood samples were taken after an overnight fast for plasma total homocysteine, insulin, and other biochemical parameters.

A significant decrease in plasma total homocysteine concentrations (P < 0.001) and waist-to-hip ratio (P = 0.041) and a significant increase in maximal oxygen consumption (P = 0.019) were recorded at 6 months, compared with baseline in the exercise group. This decrease in homocysteine was not explained by changes in anthropometric or biochemical parameters. In contrast, no significant changes in any of the variables were observed in the nonexercise group.

Our study has provided the first evidence that regular exercise significantly lowers plasma homocysteine in young overweight or obese women with PCOS, a group at increased risk of premature atherosclerosis. The precise mechanism by which exercise is associated with a reduction in homocysteine remains to be elucidated.




This article has been cited by other articles:


Home page
EndocrinologyHome page
L. Manneras, I. H. Jonsdottir, A. Holmang, M. Lonn, and E. Stener-Victorin
Low-Frequency Electro-Acupuncture and Physical Exercise Improve Metabolic Disturbances and Modulate Gene Expression in Adipose Tissue in Rats with Dihydrotestosterone-Induced Polycystic Ovary Syndrome
Endocrinology, July 1, 2008; 149(7): 3559 - 3568.
[Abstract] [Full Text] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
J. R. Ruiz, R. Sola, M. Gonzalez-Gross, F. B. Ortega, G. Vicente-Rodriguez, M. Garcia-Fuentes, A. Gutierrez, M. Sjostrom, K. Pietrzik, and M. J. Castillo
Cardiovascular Fitness Is Negatively Associated With Homocysteine Levels in Female Adolescents
Arch Pediatr Adolesc Med, February 1, 2007; 161(2): 166 - 171.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M. Yilmaz, N. Bukan, G. Ayvaz, A. Karakoc, F. Toruner, N. Cakir, and M. Arslan
The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome
Hum. Reprod., December 1, 2005; 20(12): 3333 - 3340.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Sports. Med.Home page
C A G Boreham, R A Kennedy, M H Murphy, M Tully, W F M Wallace, and I Young
Training effects of short bouts of stair climbing on cardiorespiratory fitness, blood lipids, and homocysteine in sedentary young women
Br. J. Sports Med., September 1, 2005; 39(9): 590 - 593.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E. B. Kilicdag, T. Bagis, E. Tarim, E. Aslan, S. Erkanli, E. Simsek, B. Haydardedeoglu, and E. Kuscu
Administration of B-group vitamins reduces circulating homocysteine in polycystic ovarian syndrome patients treated with metformin: a randomized trial
Hum. Reprod., June 1, 2005; 20(6): 1521 - 1528.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E. B. Kilicdag, T. Bagis, H. B. Zeyneloglu, E. Tarim, E. Aslan, B. Haydardedeoglu, and S. Erkanli
Homocysteine levels in women with polycystic ovary syndrome treated with metformin versus rosiglitazone: a randomized study
Hum. Reprod., April 1, 2005; 20(4): 894 - 899.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
D. J. Salmi, H. C. Zisser, and L. Jovanovic
Screening for and Treatment of Polycystic Ovary Syndrome in Teenagers
Experimental Biology and Medicine, May 1, 2004; 229(5): 369 - 377.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society